Ownership and insider activity for Stryker Corporation (SYK): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries.
Price
| Price | $285.22 |
| Market Cap | $109.3B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-24 | Wells Preston Wendell | J-Other | 109 | |
| 2026-07-17 | Wells Preston Wendell | J-Other | 1,776 | |
| 2026-09-22 | Wells Preston Wendell | J-Other | 962 | |
| 2026-09-01 | Baculik Emily Kay | |||
| 2026-09-01 | Baculik Emily Kay | |||
| 2026-09-01 | Baculik Emily Kay | 805 | $200K | |
| 2026-09-01 | Baculik Emily Kay | 1,490 | $400K | |
| 2026-09-01 | Baculik Emily Kay | 1,265 | $430K | |
| 2026-09-01 | Baculik Emily Kay | 918 | $360K | |
| 2026-09-01 | Baculik Emily Kay | 1,060 | $382K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.32B | $2.54B | $3.62B | $4.34B | $2.94B | $2.94B | $1.84B | $2.97B | $3.65B | $4.01B |
| Short-term Investments | $68.0M | $251.0M | $83.0M | $88.0M | $81.0M | $75.0M | $84.0M | $82.0M | $841.0M | $89.0M |
| Receivables | $1.97B | $2.20B | $2.33B | $2.89B | $2.70B | $3.02B | $3.56B | $3.77B | $3.99B | $4.04B |
| Inventory | $2.03B | $2.46B | $2.96B | $3.28B | $3.49B | $3.31B | $4.00B | $4.84B | $4.77B | $5.31B |
| Total Current Assets | $7.86B | $7.99B | $9.73B | $11.36B | $9.71B | $10.02B | $10.28B | $12.52B | $14.85B | $14.76B |
| Property, Plant & Equipment | $1.57B | $1.98B | $2.29B | $2.95B | $3.17B | $3.25B | $3.44B | $3.71B | $3.96B | $4.39B |
| Goodwill | $6.36B | $7.17B | $8.56B | $9.07B | $12.78B | $12.92B | $14.88B | $15.24B | $15.86B | $19.29B |
| Intangible Assets | $3.51B | $3.48B | $4.16B | $4.23B | $5.55B | $4.84B | $4.88B | $4.59B | $4.39B | $5.68B |
| Total Assets | $20.43B | $22.18B | $27.23B | $30.17B | $34.33B | $34.63B | $36.88B | $39.91B | $42.97B | $47.84B |
| Accounts Payable | $437.0M | $487.0M | $646.0M | $675.0M | $810.0M | $1.13B | $1.41B | $1.52B | $1.68B | $1.80B |
| Short-term Debt | $228.0M | $632.0M | $1.37B | $945.0M | $870.0M | $119.0M | $1.31B | $2.24B | $1.55B | $1.15B |
| Total Current Liabilities | $2.55B | $3.29B | $4.81B | $4.40B | $5.04B | $4.55B | $6.30B | $7.92B | $7.62B | $7.79B |
| Long-term Debt | $6.69B | $6.59B | $8.49B | $10.23B | $13.23B | $12.47B | $11.86B | $10.90B | $12.19B | $14.86B |
| Total Liabilities | $10.88B | $12.22B | $15.50B | $17.36B | $21.25B | $19.75B | $20.27B | $21.32B | $22.34B | $25.42B |
| Retained Earnings | $8.84B | $8.99B | $10.77B | $11.75B | $12.46B | $13.48B | $14.77B | $16.77B | $18.53B | $20.47B |
| Total Equity | $9.55B | $9.97B | $11.73B | $12.81B | $13.08B | $14.88B | $16.62B | $18.59B | $20.63B | $22.42B |
| Total Debt | $6.91B | $7.22B | $9.86B | $11.48B | $14.43B | $12.90B | $13.53B | $13.49B | $14.12B | $16.36B |
| Net Debt | $3.53B | $4.43B | $6.16B | $7.05B | $11.40B | $9.88B | $11.60B | $10.44B | $9.63B | $12.26B |
| Working Capital | $5.31B | $4.70B | $4.93B | $6.96B | $4.67B | $5.47B | $3.97B | $4.60B | $7.23B | $6.96B |
Financial Health
| Debt / Equity | 0.62 |
| Current Ratio | 2.16 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 4.81 |
Profitability
| Return on Equity | 14.48% |
| Return on Invested Capital | 8.53% |
| Return on Assets | 6.78% |
| Gross Margin | 65.17% |
| Operating Margin | 22.03% |
| Net Margin | 14.43% |
Related companies: AMGN · BSX · DHR · GILD · HCA · MCK · MDT
Explore sector: Healthcare · Medical - Devices
More sections of SYK: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks